Follow WOWNEWS 24x7 on:
Dr Lalchandani Labs Ltd's board approved a rights issue of up to ₹43.33 crore via equity shares on December 15, 2025, targeting eligible shareholders. This funding supports diagnostics growth amid regulatory nods under SEBI ICDR norms.
Show moreStay Ahead – Explore Now! Retail Reset: Citigroup Slashes Trent Ltd Rating to ‘Sell’ Amid Consumption Slowdown and Expansion Risks
Follow WOWNEWS 24x7 on:
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
